If you stop the treatment, the disease comes back
Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population
Gastroparesis history, pancreatitis risk, or significant gastrointestinal disease may also warrant closer provider evaluation before starting
Furthermore, retatrutide has been observed to benefit cardiovascular parameters in individuals with pre-existing cardiovascular diseases
Novo Nordisk offers savings programs to help reduce the cost for eligible patients, which can significantly lower the price for some people
Modern medicine for metabolic health and longevity Measured combines clinically proven medications with personalized care to help you lose weight, improve metabolic health, and build a longer, healthier life